Table III: Significant characteristics associated with TAS-26 scores and alexithymia
|
|
TAS-26
score |
p-value |
Alexithymic n=125 |
Non-alexithymic N=68 |
p-value |
|
Gender
m/f n
(%)
|
11.6±3.4
vs. 12.8±3.8 |
0.026* |
47
vs. 78 (58.0
vs. 69.6) |
34
vs. 34 (42.0
vs. 30.4) |
0.095** |
|
Education
high/low
n (%) |
11.7±3.4
vs. 13.2±3.9 |
0.005* |
66
vs. 59 (59.0
vs.72.8) |
46
vs. 22 (41.0
vs.27.2 ) |
0.046** OR=1.2 95%
CI 1.02
to 1.62 |
|
Combination
Therapy no/yes n
(%) |
12.2±3.7
vs. 14.3±2.8 |
0.037* |
113
vs.12 (63.1
vs.85.7) |
66
vs. 2 (40.8
vs. 14.3) |
- |
|
Glycaemic
control good/poor n
(%) |
11.2±3.5
vs. 12.9±3.7 |
0.002* |
34
vs. 91 (51.5
vs. 71.7) |
32
vs. 36 (48.5
vs. 28.3) |
0.005** OR=2.4 95%
CI 1.3
to 4.4 |
|
PBG
mg/dL |
- |
- |
261.5±115.4 |
211.5±94.2 |
0.003* |
*
Independent-Samples T Test
** Chi-Square Test